|
|
|
|
|
166. Vpliv polimorfizmov v genih za prenašalne proteine OATP1B1, OATP1B3, P-GP in MRP2Katja Delić, 2012, master's thesis Keywords: osteoporoza, raloksifen, polimorfizmi v genih, prenašalni proteini, zdravljenje osteoporoze, farmakokinetika raloksifena, farmakodinamski parametri Full text (outside link) |
|
168. Razvoj in vrednotenje novih modelov za sproščanje zdravilnih učinkovin iz trdnih peroralnih farmacevtskih oblik s simulacijo peristaltike v želodcu in črevesjuMelita Hribar, 2018, doctoral dissertation Keywords: farmacevtske oblike, trdne farmacevtske oblike, peroralne farmacevtske oblike, zdravilne učinkovine, sproščanje, farmakokinetika, prebavila, želodec, črevesje, peristaltika, simulacija, aparature, modeli, vrednotenje, optimizacija, disertacije Full text (file, 3,12 MB) |
169. A robust multi-residue method for the monitoring of 25 endocrine disruptors at ultra-trace levels in surface waters by SPE-LC-MS/MSAndrej Grobin, Robert Roškar, Jurij Trontelj, 2023, original scientific article Keywords: estrogenic endocrine disruptors, analytical methods, estrone, progesterone, LC-MS/MS analysis, validation criteria, bisphenols, hormone disruptors Full text (file, 758,18 KB) This document has more files! More... |
170. New dual inhibitors of bacterial topoisomerases with broad-spectrum antibacterial activity and in vivo efficacy against vancomycin-intermediate Staphylococcus aureusMartina Durcik, Andrej Emanuel Cotman, Žan Toplak, Štefan Možina, Žiga Skok, Maria Vittoria Piras, Nace Zidar, Janez Ilaš, Anamarija Zega, Jurij Trontelj, Danijel Kikelj, Tihomir Tomašič, Lucija Peterlin-Mašič, 2023, original scientific article Keywords: antibacterial activity, bacteria, inhibitors, genetics, inhibition, peptides and proteins Full text (file, 4,53 MB) This document has more files! More... |